As the U.S. IPO market opens back up, here's how biotech CEO Marc de Garidel says business leaders can capitalize.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results